SAMDaily.us | MOD | A | 2 PAM Autoinjectors

SAMDAILY.US - ISSUE OF JULY 03, 2022 SAM #7520
MODIFICATION

A -- 2 PAM Autoinjectors

Notice Date: 7/1/2022 10:16:57 AM
Notice Type: Solicitation
NAICS: 541714 — Research and Development in Biotechnology (except Nanobiotechnology)
Contracting Office: BARDA - ASPR / DAAPPO / BARDA DCMA WASHINGTON DC 20515 USA
ZIP Code: 20515
Solicitation Number: 75A50122R00022
Response Due: 8/15/2022 11:00:00 AM
Archive Date: 08/16/2022
Point of Contact: Jennifer Taranto, Jonathan Gonzalez
E-Mail Address: jennifer.taranto@hhs.gov, Jonathan.Gonzalez@hhs.gov
(jennifer.taranto@hhs.gov, Jonathan.Gonzalez@hhs.gov)
Description: This acquisition will allow BARDA to invest Project Bioshield funds for late-stage clinical development, regulatory approval for 2-PAM autoinjectors (as a drug/device combination product) to treat organophosphate (OP) poisoning, including nerve agents, in adult and pediatric populations, and procurement of 2-PAM autoinjectors for the SNS/CHEMPACK Program.� Questions are due on July 21, 2022. Proposals are due on August 15, 2022.� Attached to this SAM Notice are the following:� 1. Request for Proposals (Solicitation)� 2. SF33� 3. Budget Template Spreadsheet
Web Link: SAM.gov Permalink
(https://sam.gov/opp/2a3207c20add42d794dc0910affc478d/view)
Place of Performance: Address: Washington, DC, USA; Country: USA
Record: SN06376359-F 20220703/220701230054 (samdaily.us)
Source: SAM.gov Link to This Notice
(may not be valid after Archive Date)

| FSG Index | This Issue's Index | Today's SAM Daily Index Page |